Identification of Viral Variants Involved in the Transmission of Hepatitis C and Characterization of Antigenic and Functional Properties of Their Envelope Glycoproteins
NCT ID: NCT02574884
Last Updated: 2015-10-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
8 participants
INTERVENTIONAL
2011-08-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Relapse Rate in Hepatitis C Patients Treated With Peginterferon Alfa-2b Plus Ribavirin in Common Clinical Practice in France (P05484)(Completed)
NCT00725842
Pilot Study on the Feasibility of Systematic Hepatitis C Screening of Hospitalized Patients
NCT04405024
Immune Response to Hepatitis C Virus
NCT00006301
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
NCT01384383
Therapeutic Option for Hepatitis B and C: a French Cohort
NCT01953458
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Recently infected subjects
Actual population of blood donors primo-infected with HCV with specific intervention for the study : one blood sample during the inclusion visit
Blood sample (act specific of blood withdrawal for the study)
Specific intervention : blood sample (3x7 ml in total)
Retrospective cases
Population of infected blood donors in 2007, 2008 and 2009 No blood sample
No interventions assigned to this group
Individuals sources
Specific intervention for the study : one blood sample during the inclusion visit
Blood sample (act specific of blood withdrawal for the study)
Specific intervention : blood sample (3x7 ml in total)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood sample (act specific of blood withdrawal for the study)
Specific intervention : blood sample (3x7 ml in total)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* agree to participate in this study (signing the consent form or information form signed and letter of no objection for subjects contaminated by blood exposure).
These criteria are specific to contaminated subjects:
* primary infection before development of HCV antibody (seroconversion): nucleic acid testing positive in the absence of HCV antibodies.
These criteria are specific to individual sources :
* HCV antibody positive.
Exclusion Criteria
* private about freedom
* under guardianship
* under justice
* minor or major person unable to consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Tours
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chru de Tours
Tours, France, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AORT10-DB / VINTAGE VHC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.